Dr Marianne Hansson has +20 years of executive experience across life science tools, diagnostics and biotechnology, including 12 years as CEO of Atlas Antibodies and serving as CEO of A05 Diagnostics during the pandemic. She is a co-founder of ProteomEdge AB and currently holds part-time CEO roles in biotech companies Amylonix AB and Zytox Therapeutics AB. She holds a PhD in Biochemistry from KTH Royal Institute of Technology.